Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Line of PCR Workstations Provide Contamination-Free Zones on the Bench

By BiotechDaily International staff writers
Posted on 26 Aug 2013
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
A timely new product for biotech laboratories provides molecular biology investigators with a “personal cleanroom” for use while performing PCR preparations prior to the amplification of DNA and RNA.

Products in the new line of MY‑PCR Prep Stations manufactured by Mystaire Misonix (Creedmoor, NC, USA) establish bench-top personal clean zones that enable the investigator to amplify RNA and DNA while minimizing the potential for background from airborne contaminants.

The workstations, which are available in 61 cm and 81 cm-wide models, are the equivalent of Class 100 vertical laminar flow hoods with timed UV light.

Airborne contaminants are prevented from entering into the work zone through constant positive pressure HEPA filtered air. Each MY-PCR Prep Station is equipped with a built-in 254 nanometer shortwave lamp to effectively decontaminate the work area between amplifications. Safety interlocks are included on all PCR Prep Stations to prevent operator exposure to potentially harmful UV radiation.

The main chamber of MY-PCR Prep is constructed from a continuous piece of polycarbonate to prevent UV light from escaping the chamber during irradiation. Operator access is gained through the folding front polycarbonate sash, overlapped to eliminate gaps in the chamber during operation of the UV light. The work surface is white polypropylene that facilitates cleaning and disinfection.

The manufacturer reminds MY-PCR operators that the workstations are not biological safety cabinets. They are designed to provide process protection only from potential airborne contaminants found in the laboratory space.

Related Links:
Mystaire Misonix




Channels

Genomics/Proteomics

view channel
Image: Photomicrograph showing acute myeloid leukemia (AML) cells (Photo courtesy of the University of California, San Diego).

Cell Surface Protein Deletion Blocks AML Growth in Mouse Model

Cancer researchers have found that the cell surface protein tetraspanin3 (Tspan3) is required for the development and propagation of the fast-growing and extremely difficult-to-treat blood cancer, acute... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.